Keywords
adalimumab, anti-tumor necrosis factor, Crohn's, Crohn's disease, ileal Crohn's treatment ileal Crohn's, inflammatory bowel disease, infliximab, risankizumab, small bowel small bowel Crohn's therapy, small bowel Crohn's treatment, surgery in Crohn's, upadacitnib, ustekinumab, vedolizumab